The impact of pathogen reduction on ABO isoagglutinin titers in apheresis platelets
Background: Platelet transfusions are a cornerstone of modern medical care, used across various clinical contexts. Ensuring the compatibility of blood products, especially regarding ABO isoagglutinins, is critical to minimize adverse reactions. Pathogen reduction technologies have been widely adopte...
Saved in:
| Main Authors: | Mikayel Yeghiazaryan, Yembur Ahmad, Jessie Singer, Vaanush Nazaryan, Craig Fletcher, Yamac Akgun |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Hematology, Transfusion and Cell Therapy |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137925001087 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of the safety and efficacy of ABO non-identical apheresis platelets with reduced plasma transfusion
by: DIAO Ronghua, et al.
Published: (2025-07-01) -
LIPOPROTEIN APHERESIS: YESTERDAY, TODAY, TOMORROW. REVIEW
by: U. Julius, et al.
Published: (2018-09-01) -
CLINICAL APPLICATION OF HELP-APHERESIS IN FEMALE PATIENT WITH FAMILIAL HYPERCHOLESTEROLEMIA
by: OLGA L. Barbarash, et al.
Published: (2018-12-01) -
A method for identifying neoantigens through isolation of circulating tumor cells using apheresis among patients with advanced-stage cancer
by: Daiki Kobayashi, et al.
Published: (2025-07-01) -
Is it possible to regress atherosclerotic lesions with long-term treatment with lipoprotein apheresis?
by: Ulrich Julius, et al.
Published: (2024-10-01)